Aprea Therapeutics annual capital expenditures (capex)
2018
2019
2020
2023
2024
Aprea Therapeutics Capital Expenditures (CapEx) Growth & History (APRE)
Aprea Therapeutics's capital expenditures (capex) was $15,478 for fiscal 2024.
View full Aprea Therapeutics company overviewAprea Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $15,478 | −$77,615 | −83.37% |
| 2023 | 2023-12-31 | $93,093 | — | — |
| 2020 | 2020-12-31 | $25,709 | −$5,192 | −16.80% |
| 2019 | 2019-12-31 | $30,901 | $27,199 | +734.71% |
| 2018 | 2018-12-31 | $3,702 | — | — |
Aprea Therapeutics quarterly capital expenditures (capex)
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $0 | — | — |
| Q3 2024 | 2024-09-30 | $0 | — | — |
| Q2 2024 | 2024-06-30 | $7,500 | — | — |
| Q1 2024 | 2024-03-31 | $7,978 | — | — |
| Q4 2020 | 2020-12-31 | $16,290 | — | — |
| Q3 2020 | 2020-09-30 | $725 | −$9,521 | −92.92% |
| Q2 2020 | 2020-06-30 | $2,021 | — | — |
| Q1 2020 | 2020-03-31 | $12,165 | — | — |
| Q3 2019 | 2019-09-30 | $10,246 | — | — |
Aprea Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Aprea Therapeutics's capital expenditures (capex) decreased from $30,901 to $15,478, a change of −$15,423. The latest reported quarter, Q4 2024, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aprea Therapeutics source filings ↗